CN105327145A - 治疗高血压性脑出血的组合物及其制备方法 - Google Patents
治疗高血压性脑出血的组合物及其制备方法 Download PDFInfo
- Publication number
- CN105327145A CN105327145A CN201510841029.7A CN201510841029A CN105327145A CN 105327145 A CN105327145 A CN 105327145A CN 201510841029 A CN201510841029 A CN 201510841029A CN 105327145 A CN105327145 A CN 105327145A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- preparation
- radix
- hirudo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 206010008111 Cerebral haemorrhage Diseases 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 230000001631 hypertensive Effects 0.000 title claims abstract description 25
- 241000218236 Cannabis Species 0.000 claims abstract description 32
- 239000003814 drug Substances 0.000 claims abstract description 27
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims description 42
- 241000628997 Flos Species 0.000 claims description 35
- 241000237903 Hirudo Species 0.000 claims description 33
- 239000009636 Huang Qi Substances 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 241000218628 Ginkgo Species 0.000 claims description 30
- 235000011201 Ginkgo Nutrition 0.000 claims description 30
- 235000000381 ginkgo Nutrition 0.000 claims description 30
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 23
- 239000002674 ointment Substances 0.000 claims description 22
- 238000002156 mixing Methods 0.000 claims description 21
- 238000004140 cleaning Methods 0.000 claims description 19
- 239000003826 tablet Substances 0.000 claims description 18
- 238000009835 boiling Methods 0.000 claims description 14
- 229910052742 iron Inorganic materials 0.000 claims description 11
- 229940079593 drugs Drugs 0.000 claims description 10
- 240000007842 Glycine max Species 0.000 claims description 7
- 235000010469 Glycine max Nutrition 0.000 claims description 7
- 230000035613 defoliation Effects 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 8
- 231100000486 side effect Toxicity 0.000 abstract description 2
- 240000002290 Acorus calamus Species 0.000 abstract 1
- 235000006480 Acorus calamus Nutrition 0.000 abstract 1
- 240000007087 Apium graveolens Species 0.000 abstract 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 abstract 1
- 241000185686 Apocynum venetum Species 0.000 abstract 1
- 235000010591 Appio Nutrition 0.000 abstract 1
- 241001573366 Astragalus membranaceus Species 0.000 abstract 1
- 241000227283 Craibiodendron Species 0.000 abstract 1
- 241000208689 Eucommia ulmoides Species 0.000 abstract 1
- 240000002883 Ginkgo biloba Species 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 240000003717 Lonicera japonica Species 0.000 abstract 1
- 235000017617 Lonicera japonica Nutrition 0.000 abstract 1
- 240000004581 Luffa acutangula Species 0.000 abstract 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 210000004369 Blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 230000036772 blood pressure Effects 0.000 description 12
- 206010025482 Malaise Diseases 0.000 description 8
- 208000002173 Dizziness Diseases 0.000 description 7
- 206010018987 Haemorrhage Diseases 0.000 description 7
- 230000036039 immunity Effects 0.000 description 7
- 210000004185 Liver Anatomy 0.000 description 6
- 210000004072 Lung Anatomy 0.000 description 6
- 210000002784 Stomach Anatomy 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 210000001367 Arteries Anatomy 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 210000004204 Blood Vessels Anatomy 0.000 description 4
- 210000004556 Brain Anatomy 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 210000003491 Skin Anatomy 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 206010002329 Aneurysm Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 241001248531 Euchloe <genus> Species 0.000 description 3
- 210000003414 Extremities Anatomy 0.000 description 3
- 206010018852 Haematoma Diseases 0.000 description 3
- 206010019468 Hemiplegia Diseases 0.000 description 3
- 210000000214 Mouth Anatomy 0.000 description 3
- 210000003205 Muscles Anatomy 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 231100000614 Poison Toxicity 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 210000000952 Spleen Anatomy 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000000740 bleeding Effects 0.000 description 3
- 231100000319 bleeding Toxicity 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000003203 everyday Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000000414 obstructive Effects 0.000 description 3
- 230000004078 physical exercise Effects 0.000 description 3
- 230000025627 positive regulation of urine volume Effects 0.000 description 3
- 230000001737 promoting Effects 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N Arachidic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000006673 Asthma Diseases 0.000 description 2
- 229940107161 Cholesterol Drugs 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010019233 Headache Diseases 0.000 description 2
- 206010022114 Injury Diseases 0.000 description 2
- 206010061255 Ischaemia Diseases 0.000 description 2
- 210000002414 Leg Anatomy 0.000 description 2
- QZZGJDVWLFXDLK-UHFFFAOYSA-N Lignoceric acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(O)=O QZZGJDVWLFXDLK-UHFFFAOYSA-N 0.000 description 2
- 206010028851 Necrosis Diseases 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N Palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 210000001747 Pupil Anatomy 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 206010072736 Rheumatic disease Diseases 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- WWNNZCOKKKDOPX-UHFFFAOYSA-N Trigonelline Chemical compound C[N+]1=CC=CC(C([O-])=O)=C1 WWNNZCOKKKDOPX-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 201000000736 amenorrhea Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000001396 anti-anti-diuretic Effects 0.000 description 2
- 230000022534 cell killing Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 230000001882 diuretic Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000002708 enhancing Effects 0.000 description 2
- 230000003419 expectorant Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 230000001717 pathogenic Effects 0.000 description 2
- 244000052769 pathogens Species 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000001047 pyretic Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000002522 swelling Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 210000001015 Abdomen Anatomy 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000242759 Actiniaria Species 0.000 description 1
- 210000000577 Adipose Tissue Anatomy 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000006905 Allium tricoccum Nutrition 0.000 description 1
- 206010002156 Anal fistula Diseases 0.000 description 1
- 206010002383 Angina pectoris Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- RZVHIXYEVGDQDX-UHFFFAOYSA-N Anthraquinone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C(=O)C2=C1 RZVHIXYEVGDQDX-UHFFFAOYSA-N 0.000 description 1
- 241000722949 Apocynum Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000002894 Beriberi Diseases 0.000 description 1
- 210000001124 Body Fluids Anatomy 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- 210000000481 Breast Anatomy 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N Catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- 210000003169 Central Nervous System Anatomy 0.000 description 1
- 241000486666 Ceratostigma plumbaginoides Species 0.000 description 1
- 210000001627 Cerebral Arteries Anatomy 0.000 description 1
- 229940074393 Chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N Chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 210000002987 Choroid Plexus Anatomy 0.000 description 1
- 229950001002 Cianidanol Drugs 0.000 description 1
- 210000002808 Connective Tissue Anatomy 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000006111 Contracture Diseases 0.000 description 1
- 210000004351 Coronary Vessels Anatomy 0.000 description 1
- 206010061428 Decreased appetite Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 208000002251 Dissecting Aneurysm Diseases 0.000 description 1
- 206010013781 Dry mouth Diseases 0.000 description 1
- 208000001848 Dysentery Diseases 0.000 description 1
- 206010013990 Dysuria Diseases 0.000 description 1
- 208000002403 Encephalocele Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 229960002989 Glutamic Acid Drugs 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 206010018836 Haematochezia Diseases 0.000 description 1
- 210000003128 Head Anatomy 0.000 description 1
- 210000002216 Heart Anatomy 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- 210000004276 Hyalin Anatomy 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- 206010062060 Hyperlipidaemia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010020937 Hypoaesthesia Diseases 0.000 description 1
- 229960000310 ISOLEUCINE Drugs 0.000 description 1
- NDDAHWYSQHTHNT-UHFFFAOYSA-N Indapamide Chemical compound CC1CC2=CC=CC=C2N1NC(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 NDDAHWYSQHTHNT-UHFFFAOYSA-N 0.000 description 1
- 229960004569 Indapamide Drugs 0.000 description 1
- 206010022000 Influenza Diseases 0.000 description 1
- 206010022437 Insomnia Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 210000000936 Intestines Anatomy 0.000 description 1
- 206010022773 Intracranial pressure increased Diseases 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N Isoquercetin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- 210000003734 Kidney Anatomy 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline zwitterion Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 210000000265 Leukocytes Anatomy 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- 206010024855 Loss of consciousness Diseases 0.000 description 1
- 206010027327 Menstrual disease Diseases 0.000 description 1
- 230000036740 Metabolism Effects 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 210000004165 Myocardium Anatomy 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N Nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 Nifedipine Drugs 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 210000003516 Pericardium Anatomy 0.000 description 1
- 208000008425 Protein Deficiency Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 1
- 229960001285 Quercetin Drugs 0.000 description 1
- 206010038683 Respiratory disease Diseases 0.000 description 1
- 206010057190 Respiratory tract infection Diseases 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N Rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229940081967 Rutin Drugs 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 241000131808 Scolopendra Species 0.000 description 1
- 240000005498 Setaria italica Species 0.000 description 1
- 210000002356 Skeleton Anatomy 0.000 description 1
- 206010040943 Skin ulcer Diseases 0.000 description 1
- 235000008950 Sommerlauch Nutrition 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229940076185 Staphylococcus aureus Drugs 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 210000001103 Thalamus Anatomy 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- JPUKWEQWGBDDQB-QVHTVSSGSA-N Trifolin Natural products O[C@@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QVHTVSSGSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Trimethylglycine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 210000004026 Tunica Intima Anatomy 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 210000003462 Veins Anatomy 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 229940088594 Vitamin Drugs 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000003187 abdominal Effects 0.000 description 1
- 230000003213 activating Effects 0.000 description 1
- 230000001154 acute Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial Effects 0.000 description 1
- 230000003110 anti-inflammatory Effects 0.000 description 1
- 230000001754 anti-pyretic Effects 0.000 description 1
- 230000002421 anti-septic Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 210000004027 cells Anatomy 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000000994 depressed Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000000297 erysipelas Diseases 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000002949 hemolytic Effects 0.000 description 1
- 230000002443 hepatoprotective Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001976 improved Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- JPUKWEQWGBDDQB-DTGCRPNFSA-N kaempferol 3-O-β-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-DTGCRPNFSA-N 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Natural products C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- -1 luteolin glycosides Chemical class 0.000 description 1
- 230000001926 lymphatic Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000002175 menstrual Effects 0.000 description 1
- 230000003340 mental Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000035786 metabolism Effects 0.000 description 1
- 230000001617 migratory Effects 0.000 description 1
- 210000000663 muscle cells Anatomy 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 230000002107 myocardial Effects 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000002252 panizo Nutrition 0.000 description 1
- 230000001575 pathological Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000069 prophylaxis Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 229930002344 quercetin Natural products 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-β-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- 230000003014 reinforcing Effects 0.000 description 1
- 230000000552 rheumatic Effects 0.000 description 1
- 229930002876 rutin Natural products 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 231100000004 severe toxicity Toxicity 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000001340 slower Effects 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002269 spontaneous Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000004936 stimulating Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000007939 sustained release tablet Substances 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 230000002936 tranquilizing Effects 0.000 description 1
- 230000002485 urinary Effects 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229930003231 vitamins Natural products 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000002087 whitening Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Abstract
本发明公开了一种治疗高血压性脑出血的组合物,取下述重量配比的主要原料制备而成:丝瓜络8-16份,紫金莲3-12份,罗布麻6-12份,金叶子0.1-0.5份,水蛭6-14份,火麻仁20-35份,菖蒲6-15份,黄芪6-15份,金银花6-12份,石斛3-6份,银杏叶2-8份,芹菜3-9份,杜仲5-9份。本发明制备简单、服用方便、便于携带,对服用西药带来的毒副反应有很好的改善作用,对治疗高血压性脑出血有很好的作用。
Description
技术领域
本发明涉及中医中药领域,尤其是涉及一种治疗高血压性脑出血的组合物及其制备方法。
背景技术
高血压性脑出血是高血压病最严重的并发症之一,常发生于50~70岁,男性略多,冬春季易发。高血压病常导致脑底的小动脉发生病理性变化,突出的表现是在这些小动脉的管壁上发生玻璃样或纤维样变性和局灶性出血、缺血和坏死,削弱了血管壁的强度,出现局限性的扩张,并可形成微小动脉瘤。因情绪激动、过度脑力与体力劳动或其他因素引起血压剧烈升高,导致已病变的脑血管破裂出血所致。其中豆纹动脉破裂最为多见,其他依次为丘脑穿通动脉、丘脑膝状动脉和脉络丛后内动脉等。
病因血压增高是其根本原因,通常在活动和情绪激动时发病。绝大多数学者认为长期高血压可使脑动脉发生玻璃样变性,先使血管内膜下基质肿胀,内膜下有脂质沉淀,在内膜与内弹力层之间形成无结构物质,弹力降低,脆性增加。血管壁张力丧失并有纤维素性坏死,产生局部动脉在血压冲击下呈纺锤体或球状凸出,即粟粒状动脉瘤,血液还可侵入管壁而形成夹层动脉瘤。当血压骤然升高时,动脉瘤破裂引起出血。另外,高血压还可引起脑小动脉痉挛,导致远端脑组织缺血、缺氧、坏死,产生出血。此外,脑内动脉壁薄弱,中层肌细胞及外膜结缔组织少,且无外弹力层,可能导致高血压脑出血多于其他内脏出血。
临床表现:高血压性脑出血常在活动时、激动时、用力排便等时刻发病,起病急骤,往往在数分钟或数小时内病情发展到高峰。临床表现视出血部位、出血量、全身情况等因素而不同。一般发病为突然出现剧烈头痛,恶心、呕吐,并且多伴有躁动、嗜睡或昏迷。血肿对侧出现偏瘫、瞳孔的变化,早期两侧瞳孔缩小,当血肿扩大,脑水肿加重,遂出现颅内压增高,引起血肿侧瞳孔散大等脑疝危象,出现呼吸障碍,脉搏减慢,血压升高。随后即转为中枢性衰竭。
现有治疗高血压性脑出血的药物中,申请公布号CN104258113A(申请号201410579289.7)的中国专利文献公开了一种中药组合物,其特征在于,由含有天麻、钩藤、水蛭、槐花、红花、侧柏叶、石决明、杜仲和甘草等中药材制备而成。由含有以下重量份的中药材制备而成:天麻20-60、钩藤15-35、水蛭10-30、槐花10-30、红花10-30、侧柏叶10-30、石决明5-20、杜仲10-20和甘草10-60。
随着科技的发展,人们越来越意识到,中医药在防治高血压、提高患者的免疫力方面和预防脑出血有明显的优势,但是真正开发成的新药并不是很多。本发明组合物是在查阅了大量的中医文献资料和大量临床试验的基础上,针对西药产生的毒副反应,在治疗高血压性脑出血的同时,还能提高患者的免疫力,增强患者的体质,使患者能够更好的接受治疗的组合物。
发明内容
针对现有技术的不足,本发明的目的之一在于提供一种制备简单、服用方便、便于携带的组合物,对服用西药带来的毒副反应有很好的改善作用,对治疗高血压性脑出血有很好的作用。
本发明的另一目的就是提供上述组合物的制备方法。
本发明的技术方案是:
治疗高血压性脑出血的组合物,取下述重量配比的主要原料制备而成:丝瓜络8-16份,紫金莲3-12份,罗布麻6-12份,金叶子0.1-0.5份,水蛭6-14份,火麻仁20-35份,菖蒲6-15份,黄芪6-15份,金银花6-12份,石斛3-6份,银杏叶2-8份,芹菜3-9份,杜仲5-9份。
治疗高血压性脑出血的组合物,优选的方案为,取下述重量配比的主要原料制备而成:丝瓜络10-14份,紫金莲5-9份,罗布麻8-10份,金叶子0.2-0.4份,水蛭8-12份,火麻仁25-30份,菖蒲9-12份,黄芪9-13份,金银花8-10份,石斛3-5份,银杏叶4-6份,芹菜5-7份,杜仲6-8份。
治疗高血压性脑出血的组合物,更加优选的方案为,取下述重量配比的主要原料制备而成:丝瓜络12份,紫金莲7份,罗布麻9份,金叶子0.3份,水蛭10份,火麻仁28份,菖蒲10份,黄芪11份,金银花9份,石斛4份,银杏叶5份,芹菜6份,杜仲7份。
本发明还提供了将上述组合物制成药学上可接受的粉剂、膏剂和片剂。
所述粉剂的制备方法是:
(1)将丝瓜络和金叶子清洗干净,沥干水分,于无烟的炉火上烤至酥脆,研磨成细粉待用;
(2)将芹菜去叶,洗净,切成黄豆粒大小的块,置于铁板上,小火烘10-20分钟,晾至室温,研磨成细末待用;
(3)将紫金莲、罗布麻、水蛭、火麻仁、菖蒲、黄芪、金银花、石斛、银杏叶和杜仲混合,捣碎,用黄酒浸泡5-10小时,取出炒干,研磨成细末待用;
(4)将步骤(1)-(3)所得原料药混匀,过80-120目筛,分装即得粉剂。
所述膏剂的制备方法是:
1、将上述所得粉剂置于干净的容器内,加入粉剂重量1-3倍的清水,大火加热至沸腾后放入蜂蜜,一边搅拌一边煎煮1-3分钟,放凉无菌封装即得膏剂。
所述片剂的制备方法是:
①将上述所得膏剂,按照0.2-0.6g/片计量,在50-60℃下干燥,按照片剂的加工制备方法压制成圆形片状剂型,包装即得。
前面所述的制备方法,步骤(2)置于铁板上,小火烘13-18分钟(优选的,置于铁板上,小火烘15分钟)。
前面所述的制备方法,步骤(3)黄酒的用量是紫金莲、罗布麻、水蛭、火麻仁、菖蒲、黄芪、金银花、石斛、银杏叶和杜仲总重量的2-4倍(优选的,黄酒的用量是紫金莲、罗布麻、水蛭、火麻仁、菖蒲、黄芪、金银花、石斛、银杏叶和杜仲总重量的2.5-3.5倍,更佳优选的,黄酒的用量是紫金莲、罗布麻、水蛭、火麻仁、菖蒲、黄芪、金银花、石斛、银杏叶和杜仲总重量的3倍)。
前面所述的制备方法,步骤(3)用黄酒浸泡6-9小时(优选的,用黄酒浸泡7.5小时)。
前面所述的制备方法,步骤(4)混合药末过90-110目筛(优选的,混合药末过100目筛)。
前面所述的制备方法,步骤1加入粉剂重量1.5-2.5倍的清水,大火加热至沸腾后放入蜂蜜(优选的,加入粉剂重量2倍的清水,大火加热至沸腾后放入蜂蜜)。
前面所述的制备方法,步骤①按照0.3-0.5g/片计量,在53-58℃下干燥(优选的,按照0.4g/片计量,在55℃下干燥)。
本发明所用主要中药原料的药理如下:
丝瓜络:丝瓜当中的皂甙类物质、丝瓜苦味质、黏液质、木胶、瓜氨酸、木聚糖和干扰素等特殊物质具有一定的特殊作用。所含防止皮肤老化的维生素b1,增白皮肤的维生素c等成分,能保护皮肤、消除斑块,使皮肤洁白、细嫩,是不可多得的美容佳品,故丝瓜汁有“美人水”之称。味甘,性凉。归肺、肝、胃经。体轻通利。通经活络,清热解毒,利尿消肿,止血。主治胸胁胀痛,风湿痹痛,筋脉拘挛,女子经闭,乳汁不通,痰热咳嗽,热毒痈肿,痔漏,水肿,小便不利,便血,崩漏。
紫金莲:紫金莲是蓝雪花别称,性温,味甘。功用主治:活血止痛,化瘀生新。
罗布麻:基原:为夹竹桃科罗布麻属植物罗布麻的叶。成分:叶含槲皮素,异槲皮苷,金丝桃苷,三叶豆苷,云英苷,芸香苷,右旋儿茶素,蒽醌,以及谷氨酸、丙氨酸等多种氨基酸。药性:甘、微苦,凉。功用主治:清热,平肝,安神,利水。主治高血压病,眩晕,头痛,心悸,失眠,水肿尿少。
金叶子:涩微辛,温,剧毒。该物种为中国植物图谱数据库收录的有毒植物,其毒性为叶有大毒,人食叶7片,即发生呕吐、头昏、嘴舌发麻,重者可昏迷数天才恢复正常,有“半天昏”之称。叶水煎剂内服,出现视力模糊、呕吐、手脚麻木、神志昏迷;叶酒浸液内服可致四肢无力、昏睡。民间广泛用叶治疗胃疼、风湿病和跌打损伤,小鼠腹腔注射0.05—1.0g/kg叶的水煎剂,出现腹部收缩、弓背、仰头、活动减少、惊厥死亡。
水蛭:咸、苦,平。归经归肝经。功效破血通经,逐瘀消症。主治用于血瘀经闭,瘾瘕痞块,中风偏瘫,跌扑损伤。
火麻仁:为桑科大麻属植物大麻的种仁。成分:种子含胡芦巴碱,L-右旋异亮氨酸三甲铵乙内酯。种子含脂肪酸及脂类:硬脂酸,花生酸,木蜡酸,棕榈酸,棕榈油酸等。药性:甘,平。归脾、胃、大肠经。功用主治:润燥滑肠,利水,活血。主治肠燥便秘,风痹,消渴,风水,脚气,热淋,痢疾,月经不调,疮癣,丹毒。
菖蒲:别名九节菖蒲、水剑草、粉菖、山菖蒲、溪菖、石蜈蚣、野韭菜。性味功效:辛,平或微温。入心、肝、脾经。鲜品气味浓郁,辛散之力较之干品更胜,故为宣气通窍之佳品。本品既长于芳香化湿、醒脾健胃,用于治疗湿浊阴滞中焦,气机不畅、胸脘闷胀、不思饮食诸症;且又能芳华痰浊,开窍宁神,用于治疗湿浊蒙蔽清窍所引起的神智昏乱,舌苔白腻之症;并擅治痰热堕滞心包所致的神识不清,抽搐等症。
黄芪:黄芪有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。能消除实验性肾炎蛋白尿,增强心肌收缩力,调节血糖含量。黄芪不仅能扩张冠状动脉,改善心肌供血,提高免疫功能,而且能够延缓细胞衰老的进程。
金银花:现代研究证明,金银花含有绿原酸、木犀草素苷等药理活性成分,对溶血性链球菌、金黄葡萄球菌等多种致病菌及上呼吸道感染致病病毒等有较强的抑制力,另外还可增强免疫力、抗早孕、护肝、抗高血压性脑出血、消炎、解热、止血(凝血)、抑制肠道吸收胆固醇等,其临床用途非常广泛,可与其它药物配伍用于治疗呼吸道感染、菌痢、急性泌尿系统感染、高血压等40余种病症。
石斛:性味甘淡微咸,寒,归胃、肾,肺经。益胃生津,滋阴清热。用于阴伤津亏,口干烦渴,食少干呕,病后虚热,目暗不明。
银杏叶:具有活血化瘀,通络止痛,敛肺平喘,化浊降脂的功效。用于瘀血阻络,胸痹心痛,中风偏瘫,肺虚咳喘,高脂血症。
芹菜:芹菜富含蛋白质、碳水化合物、胡萝卜素、B族维生素、钙、磷、铁、钠等,同时,具有有平肝清热,祛风利湿,除烦消肿,凉血止血,解毒宣肺,健胃利血、清肠利便、润肺止咳、降低血压、健脑镇静的功效。常吃芹菜,尤其是吃芹菜叶,对预防高血压、动脉硬化等都十分有益,并有辅助治疗作用。
杜仲:现代研究杜仲具有清除体内垃圾,加强人体细胞物质代谢,防止肌肉骨骼老化,平衡人体血压,分解体内胆固醇,降低体内脂肪,恢复血管弹性,利尿清热,广谱抗菌,兴奋中枢神经,提高白血球药理作用。
本发明提供的组合物组方科学,各种剂型的制备方法简单,使得所得产品服用方便、便于携带。除此之外,本发明的优良效果还表现在:
1.本组方完全符合中医药原则和高血压性脑出血病人的身心特点,能有效的治疗高血压性脑出血。
2.所选材料皆为传统中药材,无任何毒副作用。
3.药源易得,药材成本低廉,能减轻高血压性脑出血患者的经济负担。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不限于此。
实施例1治疗高血压性脑出血的组合物,取下述重量配比的主要原料制备而成(每份取10g):丝瓜络12份,紫金莲7份,罗布麻9份,金叶子0.1份,水蛭10份,火麻仁28份,菖蒲10份,黄芪11份,金银花9份,石斛4份,银杏叶5份,芹菜6份,杜仲7份。
上述组合物粉剂的制备方法为:
(1)将丝瓜络和金叶子清洗干净,沥干水分,于无烟的炉火上烤至酥脆,研磨成细粉待用;
(2)将芹菜去叶,洗净,切成黄豆粒大小的块,置于铁板上,小火烘10分钟,晾至室温,研磨成细末待用;
(3)将紫金莲、罗布麻、水蛭、火麻仁、菖蒲、黄芪、金银花、石斛、银杏叶和杜仲混合,捣碎,用黄酒浸泡5小时,黄酒的用量是紫金莲、罗布麻、水蛭、火麻仁、菖蒲、黄芪、金银花、石斛、银杏叶和杜仲总重量的2倍,取出炒干,研磨成细末待用;
(4)将步骤(1)-(3)所得原料药混匀,过80目筛,分装即得粉剂。
本发明粉剂服用方法:每次服用取粉剂5g,开水冲服,可适当的放少许白糖,一天3次,饭后半小时服用,5天为一个疗程。
典型病例一梁XX,年龄:56岁,男。患者有高血压5年整,有时候自感身体不适时才会吃降压药,患者去年秋天因高血压导致眩晕,出现心慌气短症状,且不能活动,立即去医院就诊,诊断为脑出血,住院防治好转,由于住院费用较高,患者住院10天后就出院了,出院时医生建议服用本发明所得粉剂。
服用本实施例1所得粉剂,每次服用取粉剂5g,开水冲服,可适当的放少许白糖,一天3次,饭后半小时服用,5天为一个疗程,服用10天,不适症状减轻,能简单的说话;患者在半年的时间内一直服用实施例1所得粉剂,并且不断的进行锻炼,现在已经可以自理,并且能干轻活,血压一直很稳定。
实施例2治疗高血压性脑出血的组合物,取下述重量配比的主要原料制备而成(每份取20g):丝瓜络12份,紫金莲7份,罗布麻9份,金叶子0.5份,水蛭10份,火麻仁28份,菖蒲10份,黄芪11份,金银花9份,石斛4份,银杏叶5份,芹菜6份,杜仲7份。
上述组合物膏剂的制备方法为:
(1)将丝瓜络和金叶子清洗干净,沥干水分,于无烟的炉火上烤至酥脆,研磨成细粉待用;
(2)将芹菜去叶,洗净,切成黄豆粒大小的块,置于铁板上,小火烘20分钟,晾至室温,研磨成细末待用;
(3)将紫金莲、罗布麻、水蛭、火麻仁、菖蒲、黄芪、金银花、石斛、银杏叶和杜仲混合,捣碎,用黄酒浸泡10小时,黄酒的用量是紫金莲、罗布麻、水蛭、火麻仁、菖蒲、黄芪、金银花、石斛、银杏叶和杜仲总重量的4倍,取出炒干,研磨成细末待用;
(4)将步骤(1)-(3)所得原料药混匀,过120目筛,分装即得粉剂。
(5)将步骤(4)所得粉剂置于干净的容器内,加入粉剂重量3倍的清水,大火加热至沸腾后放入蜂蜜,一边搅拌一边煎煮3分钟,放凉无菌封装即得膏剂。
本发明膏剂服用方法:每次服用取膏剂3g,开水冲开服用,一天3次,饭后半小时服用,5天为一个疗程。
典型病例二林XX,年龄:45岁,女,某公司的职员,患者感冒后经常出现深呼吸,乏力,头晕的症状,一开始以为是出车祸后引起的后遗症,也没太在意,最近不仅是头晕,而且还有点四肢不灵活,清晨刚起床,就呕吐不止而且出现休克,立即打120,送医院后确诊为脑出血,经过手术后,保住了生命,但是其右侧胳膊和腿不受支配,医生建议服用本发明膏剂。
服用本实施例2所得膏剂,每次服用取膏剂3g,开水冲开服用,一天3次,饭后半小时服用,5天为一个疗程,不适症状减轻,能简单的说话;患者在3个月的时间内一直服用实施例2所得膏剂,并且不断的进行锻炼,现在已经可以自理,并且能干轻活,血压一直很稳定。
实施例3治疗高血压性脑出血的组合物,取下述重量配比的主要原料制备而成(每份30g):丝瓜络12份,紫金莲7份,罗布麻9份,金叶子0.2份,水蛭10份,火麻仁28份,菖蒲10份,黄芪11份,金银花9份,石斛4份,银杏叶5份,芹菜6份,杜仲7份。
上述组合物片剂的制备方法为:
(1)将丝瓜络和金叶子清洗干净,沥干水分,于无烟的炉火上烤至酥脆,研磨成细粉待用;
(2)将芹菜去叶,洗净,切成黄豆粒大小的块,置于铁板上,小火烘13分钟,晾至室温,研磨成细末待用;
(3)将紫金莲、罗布麻、水蛭、火麻仁、菖蒲、黄芪、金银花、石斛、银杏叶和杜仲混合,捣碎,用黄酒浸泡6小时,黄酒的用量是紫金莲、罗布麻、水蛭、火麻仁、菖蒲、黄芪、金银花、石斛、银杏叶和杜仲总重量的2.5倍,取出炒干,研磨成细末待用;
(4)将步骤(1)-(3)所得原料药混匀,过90目筛,分装即得粉剂。
(5)将步骤(4)所得粉剂置于干净的容器内,加入粉剂重量1.5倍的清水,大火加热至沸腾后放入蜂蜜,一边搅拌一边煎煮1分钟,放凉无菌封装即得膏剂。
(6)步骤(5)所得膏剂,按照0.3g/片计量,在53℃下干燥,按照片剂的加工制备方法压制成圆形片状剂型,包装即得。
本发明片剂服用方法:片剂采用每天3次,每次2-3片,用温开水送服,7天一个疗程。
典型病例三:萧XX,年龄:52岁,性别:女,有高血压有5年的时间,在这5年的时间里,患者出现深呼吸,乏力,头晕的症状,起初并没有以为是高血压引起的,也没太在意,最近不仅是头晕,而且还有点四肢不灵活,在干农活的过程中,突然不能自理了,失去了知觉,立即打120,送医院后确诊为脑出血,经过手术后,保住了生命,但是其右侧胳膊和腿不受支配,医生建议服用本发明膏剂。
服用本实施例3所得膏剂,片剂采用每天3次,每次2-3片,用温开水送服,7天一个疗程,不适症状减轻,能简单的说话;患者在3个月的时间内一直服用实施例3所得片剂,并且不断的进行锻炼,现在已经可以自理,并且能干轻活,血压一直很稳定。
实施例4治疗高血压性脑出血的组合物,取下述重量配比的主要原料制备而成(每份40g):丝瓜络12份,紫金莲7份,罗布麻9份,金叶子0.4份,水蛭10份,火麻仁28份,菖蒲10份,黄芪11份,金银花9份,石斛4份,银杏叶5份,芹菜6份,杜仲7份。
上述组合物片剂的制备方法为:
(1)将丝瓜络和金叶子清洗干净,沥干水分,于无烟的炉火上烤至酥脆,研磨成细粉待用;
(2)将芹菜去叶,洗净,切成黄豆粒大小的块,置于铁板上,小火烘18分钟,晾至室温,研磨成细末待用;
(3)将紫金莲、罗布麻、水蛭、火麻仁、菖蒲、黄芪、金银花、石斛、银杏叶和杜仲混合,捣碎,用黄酒浸泡9小时,黄酒的用量是紫金莲、罗布麻、水蛭、火麻仁、菖蒲、黄芪、金银花、石斛、银杏叶和杜仲总重量的3.5倍,取出炒干,研磨成细末待用;
(4)将步骤(1)-(3)所得原料药混匀,过110目筛,分装即得粉剂。
本发明粉剂服用方法:每次服用取粉剂5g,开水冲服,可适当的放少许白糖,一天3次,饭后半小时服用,5天为一个疗程。
实施例5治疗高血压性脑出血的组合物,取下述重量配比的主要原料制备而成(每份50g):丝瓜络12份,紫金莲7份,罗布麻9份,金叶子0.3份,水蛭10份,火麻仁28份,菖蒲10份,黄芪11份,金银花9份,石斛4份,银杏叶5份,芹菜6份,杜仲7份。
上述组合物胶囊剂的制备方法为:
(1)将丝瓜络和金叶子清洗干净,沥干水分,于无烟的炉火上烤至酥脆,研磨成细粉待用;
(2)将芹菜去叶,洗净,切成黄豆粒大小的块,置于铁板上,小火烘15分钟,晾至室温,研磨成细末待用;
(3)将紫金莲、罗布麻、水蛭、火麻仁、菖蒲、黄芪、金银花、石斛、银杏叶和杜仲混合,捣碎,用黄酒浸泡7.5小时,黄酒的用量是紫金莲、罗布麻、水蛭、火麻仁、菖蒲、黄芪、金银花、石斛、银杏叶和杜仲总重量的3倍,取出炒干,研磨成细末待用;
(4)将步骤(1)-(3)所得原料药混匀,过100目筛,分装即得粉剂。
(5)将步骤(4)所得粉剂置于干净的容器内,加入粉剂重量2倍的清水,大火加热至沸腾后放入蜂蜜,一边搅拌一边煎煮2分钟,放凉无菌封装即得膏剂。
(6)步骤(5)所得膏剂,按照0.4g/片计量,在55℃下干燥,按照片剂的加工制备方法压制成圆形片状剂型,包装即得。
试验例1实施例6所得组合物片剂的临床应用:2010年1月-2014年12月,在4所医院筛选400例患者,其中女性200例,男性200例。试验之前2周,对该人群进行连续观察,记录症状及变化,随机分为两组,实验组及对照组,实验组服用实施例5所得产品,对照组服用其它药品(硝苯地平缓释片、吲达帕胺片等常规药品)。
使用方法为:本发明片剂服用方法:片剂采用每天3次,每次2-3片,用温开水送服,7天一个疗程。
疗效情况判定标准:有效:服用本品一个疗程,不适症状减轻或部分消失,精力及体力增强;无效:服用本品一个疗程,不适症状无变化。结果如表1所示。
本发明选择紫金莲、罗布麻、水蛭等进行配伍,使药物产生协同作用,能更有效的治疗西药治疗引起的副反应,提高患者的免疫力。服用20天,53%以上的患者免疫力增强、不适症状有所好转;服用40天,74%以上的患者感到有所好转,不适症状改善或消失;服用60天,95%以上的感到有所好转,免疫力明显增强,不适症状改善或消失,血压稳定。
应当指出的是,具体实施方式只是本发明比较有代表性的例子,显然本发明的技术方案不限于上述实施例,还可以有很多变形。本领域的普通技术人员,以本发明所明确公开的或根据文件的书面描述毫无异议的得到的,均应认为是本专利所要保护的范围。
Claims (9)
1.治疗高血压性脑出血的组合物,其特征在于:取下述重量配比的主要原料制备而成:丝瓜络8-16份,紫金莲3-12份,罗布麻6-12份,金叶子0.1-0.5份,水蛭6-14份,火麻仁20-35份,菖蒲6-15份,黄芪6-15份,金银花6-12份,石斛3-6份,银杏叶2-8份,芹菜3-9份,杜仲5-9份。
2.根据权利要求1所述的治疗高血压性脑出血的组合物,其特征在于:取下述重量配比的主要原料制备而成:丝瓜络10-14份,紫金莲5-9份,罗布麻8-10份,金叶子0.2-0.4份,水蛭8-12份,火麻仁25-30份,菖蒲9-12份,黄芪9-13份,金银花8-10份,石斛3-5份,银杏叶4-6份,芹菜5-7份,杜仲6-8份。
3.根据权利要求1所述的治疗高血压性脑出血的组合物,其特征在于:取下述重量配比的主要原料制备而成:丝瓜络12份,紫金莲7份,罗布麻9份,金叶子0.3份,水蛭10份,火麻仁28份,菖蒲10份,黄芪11份,金银花9份,石斛4份,银杏叶5份,芹菜6份,杜仲7份。
4.根据权利要求1-3任一项所述的治疗高血压性脑出血的组合物制成药学上可接受的粉剂、膏剂和片剂,其特征在于:
所述粉剂的制备方法是:
(1)将丝瓜络和金叶子清洗干净,沥干水分,于无烟的炉火上烤至酥脆,研磨成细粉待用;
(2)将芹菜去叶,洗净,切成黄豆粒大小的块,置于铁板上,小火烘10-20分钟,晾至室温,研磨成细末待用;
(3)将紫金莲、罗布麻、水蛭、火麻仁、菖蒲、黄芪、金银花、石斛、银杏叶和杜仲混合,捣碎,用黄酒浸泡5-10小时,取出炒干,研磨成细末待用;
(4)将步骤(1)-(3)所得原料药混匀,过80-120目筛,分装即得粉剂。
5.所述膏剂的制备方法是:
将上述所得粉剂置于干净的容器内,加入粉剂重量1-3倍的清水,大火加热至沸腾后放入蜂蜜,一边搅拌一边煎煮1-3分钟,放凉无菌封装即得膏剂;
所述片剂的制备方法是:
①将上述所得膏剂,按照0.2-0.6g/片计量,在50-60℃下干燥,按照片剂的加工制备方法压制成圆形片状剂型,包装即得;
根据权利要求4所述的制备方法,其特征在于:步骤(2)置于铁板上,小火烘13-18分钟(优选的,置于铁板上,小火烘15分钟)。
6.根据权利要求4所述的制备方法,其特征在于:步骤(3)黄酒的用量是紫金莲、罗布麻、水蛭、火麻仁、菖蒲、黄芪、金银花、石斛、银杏叶和杜仲总重量的2-4倍(优选的,黄酒的用量是紫金莲、罗布麻、水蛭、火麻仁、菖蒲、黄芪、金银花、石斛、银杏叶和杜仲总重量的2.5-3.5倍,更佳优选的,黄酒的用量是紫金莲、罗布麻、水蛭、火麻仁、菖蒲、黄芪、金银花、石斛、银杏叶和杜仲总重量的3倍)。
7.根据权利要求4所述的制备方法,其特征在于:步骤(3)用黄酒浸泡6-9小时(优选的,用黄酒浸泡7.5小时)。
8.根据权利要求4所述的制备方法,其特征在于:步骤(4)混合药末过90-110目筛(优选的,混合药末过100目筛)。
9.根据权利要求4所述的制备方法,其特征在于:步骤1加入粉剂重量1.5-2.5倍的清水,大火加热至沸腾后放入蜂蜜(优选的,加入粉剂重量2倍的清水,大火加热至沸腾后放入蜂蜜)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510841029.7A CN105327145A (zh) | 2015-11-28 | 2015-11-28 | 治疗高血压性脑出血的组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510841029.7A CN105327145A (zh) | 2015-11-28 | 2015-11-28 | 治疗高血压性脑出血的组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105327145A true CN105327145A (zh) | 2016-02-17 |
Family
ID=55278051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510841029.7A Pending CN105327145A (zh) | 2015-11-28 | 2015-11-28 | 治疗高血压性脑出血的组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105327145A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107982380A (zh) * | 2018-01-08 | 2018-05-04 | 河南工程学院 | 一种心脑血管疾病治疗用中药及其加工工艺 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100784339B1 (ko) * | 2006-07-26 | 2007-12-13 | 한국 한의학 연구원 | 혼합 생약재 추출물을 유효성분으로 함유하는 항혈전제 |
CN101125164A (zh) * | 2007-08-07 | 2008-02-20 | 江西本草天工科技有限责任公司 | 降压降脂的复方罗布麻叶固体制剂及其制备方法 |
CN101856389A (zh) * | 2009-04-09 | 2010-10-13 | 刘湖 | 一种治疗心脑血管疾病的中药制剂及其应用 |
CN104224990A (zh) * | 2013-06-24 | 2014-12-24 | 山东明仁福瑞达制药股份有限公司 | 一种治疗高血压的中药 |
-
2015
- 2015-11-28 CN CN201510841029.7A patent/CN105327145A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100784339B1 (ko) * | 2006-07-26 | 2007-12-13 | 한국 한의학 연구원 | 혼합 생약재 추출물을 유효성분으로 함유하는 항혈전제 |
CN101125164A (zh) * | 2007-08-07 | 2008-02-20 | 江西本草天工科技有限责任公司 | 降压降脂的复方罗布麻叶固体制剂及其制备方法 |
CN101856389A (zh) * | 2009-04-09 | 2010-10-13 | 刘湖 | 一种治疗心脑血管疾病的中药制剂及其应用 |
CN104224990A (zh) * | 2013-06-24 | 2014-12-24 | 山东明仁福瑞达制药股份有限公司 | 一种治疗高血压的中药 |
Non-Patent Citations (1)
Title |
---|
谢道珍等: "中医药为主治疗出血性中风235例临床观察", 《中医杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107982380A (zh) * | 2018-01-08 | 2018-05-04 | 河南工程学院 | 一种心脑血管疾病治疗用中药及其加工工艺 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104127813A (zh) | 一种治疗气血两虚型褥疮的中药组合物及其制备方法 | |
CN104173517B (zh) | 治疗原发性三叉神经痛的中药制剂及制备方法 | |
CN101804110B (zh) | 一种抗血栓和降血脂的中药制剂 | |
CN106822660A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN104027719B (zh) | 具有治疗感染性心内膜炎引起的脾功能亢进肝郁脾虚型疾病的中药复方组合物及其制备方法 | |
CN105327145A (zh) | 治疗高血压性脑出血的组合物及其制备方法 | |
CN105687738A (zh) | 一种用于治疗顽固性咳嗽的中药冲剂及制备方法 | |
CN105213905A (zh) | 一种防治绝经后骨质疏松症的中药组合物及其应用 | |
CN104857121A (zh) | 一种治疗高血脂症的药物组合物及其应用 | |
CN104623304A (zh) | 一种治疗湿热毒蕴型慢性皮肤溃疡的洗剂及其制备方法 | |
CN104623040A (zh) | 一种用于创口杀菌消炎的护理组合物及其制备方法 | |
CN104689240A (zh) | 一种治疗气滞血瘀型黄褐斑的药物及其制备方法 | |
CN104353043A (zh) | 一种治疗五更泻的中药组合物及其制备方法 | |
CN104352866A (zh) | 一种治疗火毒伤津型烧伤的中药制剂及其制备方法 | |
CN103989969A (zh) | 用于治疗风寒痹阻型神经根型颈椎病的中药及其制备方法 | |
CN103520644B (zh) | 用于治疗痰瘀型高脂血症的中药组合物及其制备方法 | |
CN106729443A (zh) | 一种用于消肿止痛的中药组合物及其制备方法 | |
CN105056073A (zh) | 医治心律失常的中药制剂及制备方法 | |
CN105267895A (zh) | 用于治疗牛产后血瘀型胞衣不下的药物及其制备方法 | |
CN105362944A (zh) | 一种治疗骨科扭挫伤的中药膏剂 | |
CN105362669A (zh) | 一种治疗流行性出血热的缓释片及其制备方法 | |
CN105169014A (zh) | 一种治疗脉管炎的组合物及制法 | |
CN105125926A (zh) | 用于治疗烧烫伤的药粉及制备方法 | |
CN104800546A (zh) | 一种治疗风湿性心脏病的中药制剂及其制备方法 | |
CN104225343A (zh) | 治疗尿路感染的中药制剂及制法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160217 |
|
RJ01 | Rejection of invention patent application after publication |